Prakhar Agrawal

Stock Analyst at Cantor Fitzgerald

(0)
# 3206
Out of 5,231 analysts
59
Total ratings
35.71%
Success rate
6.33%
Average return
Main Sectors:
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
Keros Therapeutics
Downgrades: Neutral
n/a
n/a n/a 3 Jan 21, 2025
ORIC Pharmaceuticals
Reiterates: Overweight
n/a
n/a n/a 6 Jan 14, 2025
aTyr Pharma
Initiates Coverage On: Overweight
n/a
n/a n/a 1 Jan 6, 2025
TriSalus Life Scienc...
Initiates Coverage On: Overweight
10
4.89 104.5% 1 Dec 17, 2024
Madrigal Pharmaceuti...
Reiterates: Neutral
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
30.52 112.98% 12 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 10 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
n/a n/a 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
58 48
n/a n/a 2 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24
33.46 -28.27% 2 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 1
n/a n/a 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
450
1.65 27172.73% 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
21
n/a n/a 2 Jun 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
390
n/a n/a 1 Sep 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Mar 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
0.66 2021.21% 1 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
n/a n/a 1 Mar 4, 2020